|  | GCS (+)(104,72.7%) | GCS(-) (39, 27.3%) | P-value |
---|---|---|---|---|
Age | <35 | 3 | 5 | 0.035* |
 | ≥35 | 101 | 34 |  |
Tumor stage | T1-2 | 50 | 22 | 0.453 |
 | T3-4 | 54 | 17 |  |
Nodal stage | N0 | 27 | 15 | 0.375 |
 | N1-x | 23 | 14 |  |
Histologic grade | Grade I | 15 | 1 | 0.045 |
 | Grade II-Ш | 89 | 38 |  |
ER | Positive | 73 | 31 | 0.017 |
 | Negative | 19 | 20 |  |
PR | Positive | 69 | 22 | 0.271 |
 | Negative | 35 | 17 |  |
HER-2 | Positive | 22 | 17 | 0.007* |
 | Negative | 82 | 22 |  |
Ki67 | <14% | 23 | 7 | 0.652 |
 | ≥14% | 81 | 32 |  |